arrow
Back
M

Michèle Cavo

university of bologna

120H-index
1.5KPaper Count
6.9WCitation Count
Published Papers 324
Publication Date
Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus
errCancers
IF4.4
err2026-08-11
err0
errOAAI
errMichele Cavo; Melissa Bersanelli; Alessandro Corso; Carlotta Galeone; Silvia Mangiacavalli; Roberto Mina; Renato Zambello; Elisabetta Antonioli; Angelo Belotti; Cirino Botta; Gabriele Buda; Francesco Di Raimondo; Monica Galli; Francesca Gay; Massimo Offidani; Maria Teresa Petrucci; Alessandra Romano; Elena Zamagni; Antonella Semeraro; Barbara Veggia; Paolo Mariani
errShare
errSave
A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
err2025-11-25
err0
errOAAI
errI. Rizzello; I. Sacchetti; S. Barbato; V. Solli; P. Stefanoni; L. Cani; M. Quaresima; A. Belotti; N. Sgherza; M. Gentile; R. Zambello; G. Barilà; M. Celli; G. Mele; K. Mancuso; L. Pantani; P. Tacchetti; M. Talarico; M. Puppi; E. Manzato; R. Restuccia; S. Masci; S. Ghibellini; F. Bigi; M. Cavo; E. Zamagni
errShare
errSave
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework
err2025-11-02
err0
errOAAI
errMario Boccadoro; Angelo Belotti; Felice Bombaci; Sara Bringhen; Gabriele Buda; Anna Maria Cafro; Michele Caimmi; Beatrice Canali; Pier Luigi Canonico; Michele Cavo; Alessandro Corso; Lorenzo De Paoli; Daniele Derudas; Francesco Di Raimondo; Carlotta Galeone; Francesca Gay; Massimo Gentile; Nicola Giuliani; Paola La Malfa; Riccardo Mercati; Vittorio Montefusco; Pellegrino Musto; Massimo Offidani; Francesca Patriarca; Maria Teresa Petrucci; Massimo Riccaboni; Patrizia Tosi; Elena Zamagni; Renato Zambello; Francesca Fiorentino
errShare
errSave
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
err2025-10-13
err0
errOAAI
errNiccolò Bolli; Mattia D'Agostino; Tina Bagratuni; Mario Boccadoro; Michele Cavo; Christoph Driessen; Hermann Einsele; Monika Engelhardt; Francesca Gay; Norma C. Gutiérrez; Roman Hájek; Toril Holien; Cristina João; Martin Kaiser; K. Martin Kortüm; Lisa Leypoldt; Philippe Moreau; Pellegrino Musto; Enrique M. Ocio; Marc S. Raab; Leo Rasche; Fredrik Schjesvold; Tereza Sevcikova; Evangelos Terpos; Cyrille Touzeau; Niels W. C. J. Van de Donk; Mark van Duin; Katja Weisel; Elena Zamagni; Tom Cupedo; Pieter Sonneveld; Carolina Terragna
errShare
errSave
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform
err2025-10-09
err0
errOAAI
errAdrian Mosquera Orgueira; Marta Sonia Gonzalez Perez; Mattia D'Agostino; David A. Cairns; Alessandra Larocca; Juan José Lahuerta Palacios; Ruth Wester; Uta Bertsch; Anders Waage; Elena Zamagni; Carlos Pérez Míguez; Javier Alberto Rojas Martínez; Elias K. Mai; Davide Crucitti; Hans Salwender; Daniele Dall'Olio; Gastone Castellani; Manuel Piñeiro Fiel; Sara Bringhen; Sonja Zweegman; Michele Cavo; Sofía Iqbal; Jesus Maria Hernandez Rivas; Benedetto Bruno; Gordon Cook; Martin F. Kaiser; Hartmut Goldschmidt; Niels W. C. J. Van De Donk; Graham Jackson; Jesús F. San-Miguel; Mario Boccadoro; Maria-Victoria Mateos; Pieter Sonneveld
errShare
errSave
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
err2025-10-09
err0
errOAAI
errTalarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacchetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, Elena; Mancuso, K.
errShare
errSave
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
err2025-10-07
err0
errOAAI
errMarco Talarico; Gisella Vischini; Simona Barbato; Roberta Restuccia; Simone Masci; Ilaria Sacchetti; Enrica Manzato; Stefano Ghibellini; Michele Puppi; Miriam Iezza; Ilaria Rizzello; Lucia Pantani; Paola Tacchetti; Enrica Borsi; Vincenza Solli; Carolina Terragna; Claudio Agostinelli; Gaetano La Manna; Michele Cavo; Elena Zamagni; Katia Mancuso
errShare
errSave
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168
err2025-08-20
err0
PREAI
errKatia Mancuso; Simona Barbato; Francesco Di Raimondo; Francesca Gay; Pellegrino Musto; Massimo Offidani; Maria Teresa Petrucci; Elena Zamagni; Renato Zambello; Michele Cavo
errShare
errSave
Modification of Belantamab Mafodotin Dosing to Balance Efficacy and Tolerability in the DREAMM-7 and DREAMM-8 Trials
err2025-08-07
err0
errOAAI
errMaría-Victoria Mateos; Suzanne Trudel; Hang Quach; Paweł Robak; Meral Beksac; Ludek Pour; Marek Hus; Kihyun Kim; Vera Zherebtsova; Sosana Delimpasi; Tomas Jelínek; Christopher Ward; P. Joy Ho; Vladimir Vorobyev; Marcelo Pitombeira de Lacerda; Gracia Aparecida-Martinez; Ivan Spicka; Jakub Radocha; Michele Cavo; Claudio Cerchione
errShare
errSave
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions
err2025-07-23
err0
errOAAI
errPaul G. Richardson; Elisabeth K. O’Donnell; Peter O’Gorman; Lisa B. Leypoldt; Jacob Laubach; Francesca Gay; Xavier Leleu; Thierry Facon; Philippe Moreau; Meletios A. Dimopoulos; Hartmut Goldschmidt; Elias K. Mai; Michele Cavo; Katja C. Weisel; Jesus G. Berdeja; Robert Z. Orlowski; Meral Beksaç; Aurore Perrot; Joseph Mikhael; Thomas Martin
errShare
errSave
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
err2025-07-15
err0
PREAI
errVania Hungria; Paweł Robak; Marek Hus; Vera Zherebtsova; Christopher Ward; P Joy Ho; Roman Hájek; Kihyun Kim; Sebastian Grosicki; Hanlon Sia; Adam Bryant; Marcelo Pitombeira de Lacerda; Gracia Aparecida Martinez; Anna Sureda Balarí; Irwindeep Sandhu; Claudio Cerchione; Peter Ganly; Meletios A Dimopoulos; Chengcheng Fu; Mamta Garg; Al-Ola Abdallah; Moshe E Gatt; Albert Oriol Rocafiguera; Michele Cavo; Robert Rifkin; Tomoaki Fujisaki; Michał Mielnik; Joseph Ficek; Alejandro Mantero; Nick Pirooz; Sybil Varghese; Joe Lee; Astrid McKeown; Rachel Rogers; Hena Baig; Lydia Eccersley; Sumita Roy-Ghanta; Pralay Mukhopadhyay; Jacqueline Nielsen; Joanna Opalinska; María-Victoria Mateos
errShare
errSave
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
err2025-07-07
err0
PREAI
errMeletios A. Dimopoulos; Evangelos Terpos; Mario Boccadoro; Philippe Moreau; María-Victoria Mateos; Sonja Zweegman; Gordon Cook; Monika Engelhardt; Michel Delforge; Roman Hajek; Fredrik Schjesvold; Francesca Gay; Salomon Manier; Katja C. Weisel; Martin Kaiser; Niels W. C. J. van de Donk; Elena Zamagni; Paula Rodriguez-Otero; Aurore Perrot; Christoph Driessen; Jelena Bila; Edward Laane; Dominik Dytfeld; Cyrille Touzeau; Meral Beksac; Marc S. Raab; Michele Cavo; Mohamad Mohty; Andrew Spencer; Heinz Ludwig; Hermann Einsele; Jesus San-Miguel; Pieter Sonneveld
errShare
errSave
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
err2025-06-27
err0
PREAI
errShaji K Kumar; Simon J Harrison; Michele Cavo; Javier de la Rubia; Rakesh Popat; Cristina Gasparetto; Vania Hungria; Hans Salwender; Kenshi Suzuki; Inho Kim; Maika Onishi; Grace Ku; Rajvineeth Pothacamury; Muhammad Jalaluddin; Jiewei Zeng; Jeremy A Ross; Edyta Dobkowska; Philippe Moreau
errShare
errSave
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index
err2025-06-04
err0
PREAI
errDaniela Krepper; Francesco Sparano; Johannes M. Giesinger; Gianluca Gaidano; Pasquale Niscola; Katia Codeluppi; Elisabetta Antonioli; Catello Califano; Lajos Floro; Ombretta Annibali; Claudio Fozza; Agostino Tafuri; Patrizio Mazza; Leonardo Potenza; Marco Vignetti; Michele Cavo; Maria Teresa Petrucci; Fabio Efficace
errShare
errSave
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison
err2025-05-12
err0
errOAAI
errPuig, N; Diels, J; van Sanden, S; Mendes, J; Burnett, H; Cichewicz, A; Lee, S; Hernando, T; Schecter, JM; Lendvai, N; Patel, N; Sanchez-Pina, JM; Rocchi, S; Mina, R; Corradini, P; Cavo, M; Miguel, JS; Shune, L; Khan, AM; Sidana, S; Leleu, X; Manier, S; Lipe, B; Weisel, K; Martinez-Lopez, J
errShare
errSave
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
errCANCERS
IF4.4
err2025-04-30
err0
errOAAI
errMancuso, Katia; Talarico, Marco; Manzato, Enrica; Barbato, Simona; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele
errShare
errSave
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability
err2025-04-24
err0
errOAAI
errMancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona
errShare
errSave
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor
err2025-02-03
err0
PREAI
errOcadlikova, Darina; Fiordi, Benedetta; Trabanelli, Sara; Salvestrini, Valentina; Ciciarello, Marilena; Forte, Dorian; Campazzi, Emma; Vitali, Letizia; Cipollitta, Serenella C.; Pegoraro, Anna; Jandus, Camilla; Di Virgilio, Francesco; Adinolfi, Elena; Cavo, Michele; Curti, Antonio
errShare
errSave
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
err2025-02-01
err1
PREAI
errMusto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; de Larrea, C. Fernandez; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosinol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hajek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Blade, J.; Moreau, P.; Mateos, M. -V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P.
errShare
errSave
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma
err2024-12-09
err0
errOAAI
errMancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele
errShare
errSave